HMA/EMA Multi-stakeholder Forum on Artificial Intelligence
HMA and EMA convene a multi-stakeholder forum on AI and data to build trustworthy AI on solid data foundations.
Slovenia JAZMP · SloveniaHMA and EMA convene a multi-stakeholder forum on AI and data to build trustworthy AI on solid data foundations.
Slovenia JAZMP · SloveniaSlovenia's food and veterinary authority imposed special quality control requirements for veterinary medicinal products on 10 July 2026.
Slovenia JAZMP · SloveniaTechnical issue with external email reception at JAZMP was resolved on 9 October around 11:00.
Slovenia JAZMP · SloveniaJAZMP publishes professional guidance on switching adult patients from Kreon 25,000 to Panzynorm forte.
Slovenia JAZMP · SloveniaInternational campaign 2–8 November 2026 to raise awareness of adverse drug reaction reporting.
Slovenia JAZMP · SloveniaJAZMP publishes updated list of national medicine identifiers and product codes submitted by stakeholders for regulatory implementation.
Slovenia JAZMP · SloveniaPRAC committee has initiated a safety review of parenteral iron medicines to assess the risk of low blood phosphate levels and associated bone complications.
Slovenia JAZMP · SloveniaJAZMP calls wholesalers to temporarily import cinacalcet 30 mg film-coated tablets from other EU member states due to supply disruption.
Slovenia JAZMP · SloveniaOdbor za varnost zdravil (PRAC) pri Evropski agenciji za zdravila (EMA) je v objavi s seje, ki je potekala od 31. avgusta do 3. septembra, izpostavil naslednje: Začetek pregleda varnosti […]
Slovenia JAZMP · SloveniaTelephone access to JAZMP may experience intermittent disruptions over the next two days due to technical maintenance work.
Slovenia JAZMP · SloveniaJAZMP publishes specialty guidance on patient prioritization criteria for prescribing pancreatic enzyme replacement therapy Kreon.
Slovenia JAZMP · SloveniaThe ninth issue of the Pharmacovigilance Bulletin is now available, featuring routine notices and reporting on adverse drug effects in 2025.
Slovenia JAZMP · SloveniaSlovenia's medicines agency announces publication of the seventh edition of the national pharmaceutical formulary on 28 August 2026.
Slovenia JAZMP · SloveniaZainteresirano javnost obveščamo, da je Ministrstvo za zdravje (v nadaljevanju: MZ) na podlagi četrtega odstavka 180. člena Zakona o zdravilih (Uradni list RS, št. 17/14, 66/19, 102/24 – ZZKZ, 24/25, […]
Slovenia JAZMP · SloveniaDirect healthcare professional communication issued on meningioma risk associated with medicines containing desogestrel or etonogestrel.
Slovenia JAZMP · SloveniaJAZMP invites wholesalers to temporarily import mefloquine 250 mg tablets and other medicines from other EU member states to address supply shortages.
Slovenia JAZMP · SloveniaOdbor za varnost zdravil (PRAC) pri Evropski agenciji za zdravila (EMA) je v objavi s seje, ki je potekala od 6. do 9. julija, izpostavil naslednje: Nove informacije za zdravstvene […]
Slovenia JAZMP · SloveniaSlovene medicines and medical devices agency issues safety corrective action for IALUADAPTER/UroDapter devices and IALURIL Prefill system issued by Pharmico Medical.
Slovenia JAZMP · SloveniaJAZMP publishes specialist guidance on clinical management during shortage of isosorbide mononitrate oral medicines.
Slovenia JAZMP · SloveniaJAZMP publishes safety corrective action notices for medical devices received from manufacturers or authorised representatives.
Slovenia JAZMP · SloveniaJAZMP publishes safety corrective action notices for medical devices received from manufacturers or authorised representatives.
Slovenia JAZMP · SloveniaDirect Healthcare Professional Communication issued regarding a new hepatic safety risk associated with Ocrevus (ocrelizumab).
Slovenia JAZMP · SloveniaJAZMP publishes safety corrective action notices for medical devices received from manufacturers or authorised representatives.
Slovenia JAZMP · SloveniaUpdated information on Amoxiclav 400 mg/57 mg per 5 ml powder for oral suspension regarding new formulation and suspension preparation method.
Slovenia JAZMP · SloveniaRisk of medication errors identified with new Rybelsus formulation launching in Slovenia in early September.
Slovenia JAZMP · SloveniaDirect healthcare professional communication issued with updated recommendations to reduce risk of serious cardiovascular adverse events.
Slovenia JAZMP · SloveniaDirect Healthcare Professional Communication issued regarding risk of medication errors due to introduction of new formulation of Rybelsus.
Slovenia JAZMP · SloveniaJAZMP clarifies it did not order destruction of samples held by Biobanka d.o.o., responding to parental inquiries.
Slovenia JAZMP · SloveniaAll samples not transferred to other storage providers or donated for research purposes were destroyed due to temperature rise.
Slovenia JAZMP · Slovenia